American Healthcare REIT, Inc. $AHR Shares Sold by J.W. Cole Advisors Inc.

J.W. Cole Advisors Inc. lowered its position in shares of American Healthcare REIT, Inc. (NYSE:AHR) by 33.0% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 64,923 shares of the company’s stock after selling 32,013 shares during the quarter. J.W. Cole Advisors Inc.’s holdings in American Healthcare REIT were worth $2,385,000 as of its most recent filing with the SEC.

Other hedge funds have also recently bought and sold shares of the company. Vanguard Group Inc. grew its stake in American Healthcare REIT by 22.4% during the first quarter. Vanguard Group Inc. now owns 18,795,192 shares of the company’s stock worth $569,494,000 after buying an additional 3,437,861 shares during the period. Invesco Ltd. raised its stake in shares of American Healthcare REIT by 1,543.1% in the 1st quarter. Invesco Ltd. now owns 5,022,455 shares of the company’s stock valued at $152,180,000 after acquiring an additional 4,716,792 shares during the period. Geode Capital Management LLC raised its stake in shares of American Healthcare REIT by 20.5% in the 2nd quarter. Geode Capital Management LLC now owns 4,578,867 shares of the company’s stock valued at $174,882,000 after acquiring an additional 779,109 shares during the period. Alliancebernstein L.P. lifted its holdings in shares of American Healthcare REIT by 350.7% during the 1st quarter. Alliancebernstein L.P. now owns 4,559,365 shares of the company’s stock valued at $138,149,000 after acquiring an additional 3,547,635 shares in the last quarter. Finally, Prudential Financial Inc. boosted its position in American Healthcare REIT by 5.5% during the 2nd quarter. Prudential Financial Inc. now owns 2,732,663 shares of the company’s stock worth $100,398,000 after purchasing an additional 141,427 shares during the period. Hedge funds and other institutional investors own 16.68% of the company’s stock.

American Healthcare REIT Stock Performance

American Healthcare REIT stock opened at $50.49 on Friday. American Healthcare REIT, Inc. has a 52 week low of $26.40 and a 52 week high of $50.80. The company has a current ratio of 0.44, a quick ratio of 0.44 and a debt-to-equity ratio of 0.37. The stock has a market cap of $8.93 billion, a P/E ratio of 360.63, a price-to-earnings-growth ratio of 2.10 and a beta of 0.98. The stock has a 50 day moving average of $44.75 and a 200-day moving average of $40.43.

American Healthcare REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 17th. Shareholders of record on Tuesday, September 30th were paid a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a yield of 2.0%. The ex-dividend date was Tuesday, September 30th. American Healthcare REIT’s dividend payout ratio is 714.29%.

Insider Buying and Selling at American Healthcare REIT

In other news, Director Jeffrey T. Hanson sold 20,010 shares of the stock in a transaction dated Monday, November 10th. The shares were sold at an average price of $49.68, for a total transaction of $994,096.80. Following the transaction, the director owned 21,798 shares of the company’s stock, valued at approximately $1,082,924.64. This trade represents a 47.86% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Mark E. Foster sold 3,850 shares of American Healthcare REIT stock in a transaction dated Wednesday, September 3rd. The stock was sold at an average price of $41.89, for a total value of $161,276.50. Following the completion of the transaction, the executive vice president owned 59,100 shares of the company’s stock, valued at $2,475,699. This trade represents a 6.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 25,360 shares of company stock valued at $1,229,398. 0.92% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several research analysts have commented on the company. Zacks Research raised American Healthcare REIT from a “hold” rating to a “strong-buy” rating in a research report on Friday, October 17th. Truist Financial increased their target price on American Healthcare REIT from $46.00 to $53.00 and gave the company a “buy” rating in a research note on Wednesday. UBS Group raised their target price on American Healthcare REIT from $51.00 to $56.00 and gave the company a “buy” rating in a report on Monday, November 17th. Weiss Ratings restated a “hold (c)” rating on shares of American Healthcare REIT in a report on Wednesday, October 8th. Finally, Morgan Stanley increased their price objective on shares of American Healthcare REIT from $52.00 to $55.00 and gave the company an “overweight” rating in a research report on Thursday, November 20th. Two analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Buy” and an average target price of $51.64.

About American Healthcare REIT

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.